What question did this study set out to answer?

To identify genes and pathways driving genomic evolution in multiple myeloma and validate their roles in genomic instability.

December 8, 2025Blood

Integrated genomic analysis identifies polo-like kinase 4 (PLK4) as a key regulator of chromosomal stability and growth in multiple myeloma

View Full Paper

Ask AI

Bookmark

Authors

Integrated genomic analysis identifies PLK4's role in growth rate and genomic instability in multiple myeloma, suggesting it as a target for therapy.

To identify genes and pathways driving genomic evolution in multiple myeloma and validate their roles in genomic instability.
Integrated analysis of gene expression and copy number data from multiple human cancers, including multiple myeloma.
Assessment of genomic instability through copy number events and correlation with gene expression data.
Evaluation of PLK4's effect on cell growth and chromosomal integrity via gain and loss of function studies.
32 genes correlated with genomic instability across ten human cancers, including multiple myeloma.
PLK4 expression was elevated in multiple myeloma cell lines and its knockdown reduced genomic instability and growth rate.
A specific PLK4 inhibitor selectively inhibited viability in multiple myeloma cell lines with high therapeutic index.

Zhao et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Integrated genomic analysis identifies PLK4's role in growth rate and genomic instability in multiple myeloma, suggesting it as a target for therapy.